Printer Friendly

PerkinElmer acquires microarray company spectral genomics.

Boston, MA 5/1/06--PerkinElmer has acquired the assets of Spectral Genomics for an undisclosed sum. Spectral Genomics provides microarrays and software for the identification of chromosomal abnormalities related to the study of cancer and pre- and post-natal genetic disorders. "Spectral Genomics' innovative technologies are highly complementary to our current molecular medicine and genetic screening offerings," said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences.

According to PerkinElmer, array-based karyotyping is expected to replace microscope-based Fluorescent In-Situ Hybridization (FISH) techniques for chromosome analysis. Spectral Genomics' SpectralChip is a nucleic acid array designed for comparative genomic hybridization applications. This technology fits well with PerkinElmer's focus on personalized medicine and new technologies for diagnostics.
COPYRIGHT 2006 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive Briefing: News, Trends & Market Intelligence for Instrument Executives
Publication:Instrument Business Outlook
Geographic Code:1USA
Date:May 15, 2006
Previous Article:Thermo buys Fisher Scientific for $10.6 billion.
Next Article:QIAGEN buys nucleic acid purification provider.

Related Articles
Random Samples.
Executive Briefing.
Random Samples.
Companies. (Random Samples).
Random samples: products.
Beckman Coulter buys orchid instrument business. (Executive briefing: news, trends & market intelligence for instrument executives).
PerkinElmer: refocused and on the move.
Life science instrumentation: dynamic growth.
2007 mergers & acquisitions review.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters